BMO Capital analyst Thanos Moschopoulos initiates coverage on Thinkific Labs (TSX:THNC) with a Outperform rating and announces Price Target of C$17.
Mizuho Maintains Buy on Assembly Biosciences, Lowers Price Target to $3
Mizuho analyst Salim Syed maintains Assembly Biosciences (NASDAQ:ASMB) with a Buy and lowers the price target from $14 to $3.